Symtuza
My Prescription
Payment
Select pharmacy
$4,602.38
Print or send this coupon to your phone
AlbertsonsPowered byAbout Symtuza
Drug Details
Symtuza is a medication designed to manage HIV infection. It combines four active ingredients—darunavir, cobicistat, emtricitabine, and tenofovir alafenamide—into a single daily tablet taken with food. This combination helps reduce the amount of HIV in the body, enhancing the immune system's function and reducing the risk of HIV-related complications like infections or cancer, thereby improving overall quality of life. Darunavir acts as a protease inhibitor, while cobicistat boosts its effectiveness. Emtricitabine and tenofovir alafenamide are classified as NRTIs, working together to suppress the virus. Although Symtuza is not a cure for HIV, it plays a crucial role in treatment. Patients should follow their doctor’s instructions precisely, continue using protective measures during sexual activity, and avoid sharing personal items that might transmit the virus. Always consult with healthcare professionals for personalized medical advice. Common side effects include nausea and diarrhea.
Price history for Symtuza
30 Tablets, 800-150-200-10MG
Average retail price for Symtuza
Average SaveHealth price for Symtuza
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Symtuza dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 800-150-200-10MG | 30 Tablets | $4,602.58 | $153.42 |
Symtuza FAQs
Symtuza is used for the treatment of HIV-1 infection in adults and certain pediatric patients. It is a combination antiretroviral medication that helps to control the virus, thereby improving the immune system function and reducing the risk of developing HIV-related complications.
Symtuza is not approved for use as pre-exposure prophylaxis (PrEP). It is a medication used for the treatment of HIV-1 infection in certain patients. PrEP typically involves medications like Truvada or Descovy, which are specifically approved for reducing the risk of HIV infection in individuals at high risk.
The cost of Symtuza can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or patient assistance programs. It is recommended to check with local pharmacies or consult with a healthcare provider or insurance company for the most accurate and up-to-date pricing information.
Symtuza is not typically used for post-exposure prophylaxis (PEP). PEP usually involves a combination of antiretroviral medications specifically recommended for this purpose, such as tenofovir, emtricitabine, and raltegravir or dolutegravir. It is important for individuals to consult with a healthcare provider to determine the most appropriate PEP regimen based on current guidelines and individual circumstances.
Symtuza is not commonly associated with weight gain as a side effect. However, individual responses to medication can vary, and some patients may experience changes in weight. If there are concerns about weight changes while taking Symtuza, it is advisable to consult a healthcare provider for personalized advice and management.